Home » Testimonials » Novate


“Novate Medical are developing the world’s first bio-convertible Inferior Vena Cava (IVC) filter, designed to protect patients at transient risk of pulmonary embolism (PE). Novate are currently enrolling patients for an IDE clinical trial in the U.S. Our close working relationship with CADFEM has allowed us to use their expertise with the ANSYS suite, to drive the design process in a cost efficient and timely manner. CADFEM’s expertise with Finite Element Analysis has been instrumental to Novate in designing a robust vascular implant that can withstand the in vivo cyclical fatigue loading conditions generated in the IVC throughout the lifetime of the device. Additionally Novate have leveraged CADFEM’s expertise with Computational Fluid Dynamics to optimise the hemodynamic performance of the filter geometry through blood flow simulations in the IVC. Data generated from CADFEM simulations has been used by Novate for regulatory submissions with the FDA.”

Damien Ryan, Senior R&D Engineer, Novate

Select Country: